CIBC Private Wealth Group’s Maravai LifeSciences MRVI Stock Holding History

CIBC Private Wealth Group’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$907K	Sell	279,224 -132,266	-32%	-$445K	﹤0.01%	726
2025 Q3	$1.18M	Hold	411,490	–	–	﹤0.01%	665
2025 Q2	$992K	Sell	411,490 -124	-0%	-$261	﹤0.01%	671
2025 Q1	$774K	Buy	411,614 +410,939	+60,880%	+$1.62M	﹤0.01%	697
2024 Q4	$4.14K	Hold	675	–	–	﹤0.01%	2533
2024 Q3	$5.61K	Buy	+675	New	+$5.83K	﹤0.01%	2564
2021 Q3	–	Sell	-89,192	Closed	-$3.72M	–	991
2021 Q2	$3.72M	Buy	89,192 +11,482	+15%	+$445K	0.01%	441
2021 Q1	$2.77M	Buy	+77,710	New	+$2.57M	0.01%	486

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIBC Private Wealth Group's MRVI Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its Maravai LifeSciences (MRVI) stake by 32% in Q4 2025, selling an estimated $445K and leaving 279,224 shares worth $907K. The position accounts for ﹤0.01% of the portfolio, ranked #726.

CIBC Private Wealth Group first reported a position in MRVI in Q1 2021 and has held it in 8 quarters since. The position peaked at $3.72M in Q2 2021. 159 funds tracked by Wall St. Rank hold MRVI as of Q4 2025.

CIBC Private Wealth Group held 279,224 shares of Maravai LifeSciences worth $907K as of Q4 2025.
CIBC Private Wealth Group sold 132,266 Maravai LifeSciences shares in Q4 2025, an estimated $445K.
Maravai LifeSciences made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #726 holding.
CIBC Private Wealth Group first reported a position in Maravai LifeSciences in Q1 2021 and has held it in 8 quarters since.
CIBC Private Wealth Group's Maravai LifeSciences position peaked at $3.72M in Q2 2021.
159 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.